Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study.
Sorbye H, Hjortland GO, Vestermark LW, Ladekarl M, Svensson J, Sundlöv A, Janson ET, Garresori H, Hofsli E, Kersten C, Elvebakken H, Pfeiffer P, Morken S, Assmus J, Lothe IMB, Tabaksblat E, Knigge U, Couvelard A, Perren A, Langer SW.
Sorbye H, et al.
Br J Cancer. 2025 Aug;133(3):316-324. doi: 10.1038/s41416-025-03054-w. Epub 2025 May 17.
Br J Cancer. 2025.
PMID: 40382522
Free PMC article.